Skip to main content
. 2020 Jun 19;73(9):749–757. doi: 10.1016/j.rec.2020.04.025

Figure 2.

Figure 2

Antithrombotic approach to patients admitted for covid-19 with prior anticoagulant therapy. AF, atrial fibrillation; CrCl, creatinine clearance; DOAC, direct-acting oral anticoagulant; INR, international normalized ratio; LMWH, low-molecular-weight heparin; OAC, oral anticoagulation; VKA, vitamin K antagonists; VTE, venous thromboembolic disease.